Literature DB >> 8195760

Postmortem clomipramine: therapeutic or toxic concentrations?

I M McIntyre1, C V King, S M Cordner, O H Drummer.   

Abstract

Postmortem blood and liver concentrations of clomipramine were determined in ten cases by high performance liquid chromatography (HPLC). Blood concentrations ranged from 0.21 to 4.9 mg/L, and liver concentrations from 7.0 to 320 mg/kg. Two cases associated with clomipramine toxicity were clearly differentiated from other cases by the analysis of liver. The concentrations of clomipramine in these two cases were 3.3 and 1.8 mg/L in blood, and 280 and 320 mg/kg in liver. The liver concentrations were 10 to 30 fold greater in the deaths associated with drug toxicity compared with the other cases. One case, where cardiac blood was collected in place of femoral blood, showed a high blood concentration (4.9 mg/L), but an arguably therapeutic liver concentration (13 mg/kg). The analysis of femoral blood together with liver provides the best guide as to the significance of post-mortem clomipramine concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195760

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  3 in total

1.  The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens.

Authors:  Dimitri Gerostamoulos; Jochen Beyer; Voula Staikos; Penny Tayler; Noel Woodford; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2012-05-22       Impact factor: 2.007

Review 2.  Liver and peripheral blood concentration ratio (L/P) as a marker of postmortem drug redistribution: a literature review.

Authors:  Iain M McIntyre
Journal:  Forensic Sci Med Pathol       Date:  2013-11-07       Impact factor: 2.007

3.  The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

Authors:  Pierre Baumann; Sven Ulrich; Gabriel Eckermann; Manfred Gerlach; Hans-Joachim Kuss; Gerd Laux; Bruno Müller-Oerlinghausen; Marie Luise Rao; Peter Riederer; Gerald Zernig; Christoph Hiemke
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.